Share Sale vs Asset Sale in the UK: Which Is Best for Private-equity Sellers and Buyer-side Risk Allocation

Every private-equity exit and every mid-market acquisition in the United Kingdom begins with one structural question: share sale vs asset sale UK, which route delivers the best net outcome for both sides of the table? The answer drives tax liability, indemnity exposure, lender security, employee transfer mechanics and the speed at which you can close. In 2026, elevated debt costs and tighter intercreditor behaviour have sharpened this choice: buyers push harder for asset purchases that ring-fence historic liabilities, while sellers defend the share sale route to capture Capital Gains Tax reliefs and achieve a clean exit.

This article sets out the six dimensions that determine the right private equity deal structure, tax, cost, liability, financing, regulatory and enforceability, and delivers a concrete decision framework you can apply before signing heads of terms.

Share Sale: What It Is, When It Applies and Who It Suits

In a share sale the buyer acquires the shares in the target company. The company itself, with every contract, licence, employee relationship, asset and liability on its books, continues as before. Only the ownership changes. The buyer steps into the shoes of the former shareholders and inherits the company’s entire history, including contingent and unknown liabilities.

For PE sellers, the share sale is typically the preferred exit route. Proceeds flow directly to shareholders and are subject to Capital Gains Tax (CGT) rather than Corporation Tax. Where Business Asset Disposal Relief (BADR) is available, qualifying individual sellers pay CGT at 10% on gains up to the BADR lifetime limit, rather than the standard higher rate of 20% on business-asset disposals. Stamp duty is payable by the buyer at 0.5% of the consideration for the shares, a comparatively modest transaction tax. The mechanics are straightforward: a share purchase agreement (SPA), completion accounts or locked-box pricing, and, in most PE-backed deals, warranty and indemnity (W&I) insurance to bridge the gap between seller and buyer risk appetite.

The trade-off is liability exposure. Because the company’s entire history transfers, buyers face broader due diligence requirements and typically demand comprehensive seller warranties, tax indemnities with longer survival periods, and either an escrow or W&I policy to back them.

Share sale: pros and cons at a glance

Asset Sale: What It Is, When It Applies and Who It Suits

In an asset sale the buyer purchases specifically identified assets, plant, equipment, IP, stock, goodwill, selected contracts, and agrees to assume only those liabilities explicitly listed in the asset purchase agreement. The selling company continues to exist post-completion and retains all liabilities not expressly transferred. This “cherry-picking” ability is the asset sale’s central attraction for buyers.

For sellers, the tax picture is less favourable. The sale proceeds belong to the company, which pays Corporation Tax on any chargeable gains at the main rate of 25% (for companies with profits above £250,000). If shareholders then want to extract the remaining cash, a further layer of tax applies, either income tax on dividends or CGT on a liquidation distribution, creating the well-known “double taxation” problem. VAT may also be chargeable on the assets sold, although a Transfer of a Going Concern (TOGC) can disapply VAT where the buyer carries on the same kind of business and the statutory conditions are met. Where property forms part of the asset base, Stamp Duty Land Tax (SDLT) replaces the 0.

5% stamp duty that applies to shares and is typically a larger cost.

Employees engaged in the transferred undertaking move to the buyer automatically under the Transfer of Undertakings (Protection of Employment) Regulations 2006 (TUPE). TUPE compliance, including information and consultation obligations, adds complexity and timeline risk to asset sales.

Asset sale: pros and cons at a glance

Share Sale vs Asset Sale: Side-by-Side Comparison

The table below sets out the asset sale vs share sale pros and cons across every dimension that matters at heads of terms. Use it as a negotiation checklist.

Seller priority summary: the share sale route almost always delivers higher net proceeds for individual shareholders thanks to CGT treatment and potential BADR, fewer third-party consents, and faster time to cash.

Buyer priority summary: the asset sale route offers superior liability protection, a valuable tax step-up on acquired assets, and a cleaner security package for acquisition lenders, at the cost of greater administrative complexity and TUPE compliance.

Dimension-by-Dimension Analysis

Tax Implications: Share Sale vs Asset Sale

Tax is usually the single largest factor in the share sale vs asset sale tax implications debate. The table below quantifies the key differences.

PE seller implication: where BADR is available, an individual seller’s effective tax rate on a share sale can be half the rate a company pays on an asset disposal, before accounting for double taxation on extraction. This differential makes share sales the default PE exit preference.

PE buyer implication: the asset sale’s tax step-up directly improves post-acquisition cash flow through enhanced depreciation and amortisation deductions, partially offsetting the higher purchase price sellers often demand to compensate for the less favourable tax treatment.

Transaction Costs and Timing

Beyond headline tax, transaction costs and timeline differences can shift the commercial equation.

Share sales carry lower aggregate transaction costs and close faster, which is why PE sponsors with fund-life pressure overwhelmingly favour them. Asset sales incur additional legal complexity, each material contract requires counterparty consent for novation or assignment, and any failure to obtain consent can leave critical commercial relationships in limbo.

Liability Allocation and Indemnities

Liability allocation is where the share sale vs asset sale UK decision becomes a negotiation flashpoint in PE transactions.

• Share sale warranty package: Sellers typically give comprehensive warranties covering the company’s financial statements, tax compliance, material contracts, employment, litigation and environmental matters. General warranties commonly survive for 18–24 months post-completion; tax warranties and indemnities survive for 7 years. Indemnity caps in mid-market PE deals usually range from 25% to 100% of the enterprise value for fundamental warranties, with lower caps (10–20%) for general business warranties.
• Asset sale warranty package: Warranties are narrower, focused on title to the specific assets sold, capacity and authority. Sellers give fewer operational warranties because the buyer chose which assets to acquire. Indemnity caps are correspondingly smaller and survival periods shorter.
• W&I insurance: In PE share sales, W&I insurance has become standard. It allows sellers to achieve a clean exit with minimal escrow while giving buyers recourse to an insurer rather than a departing shareholder group. In asset sales, W&I usage is less prevalent and underwriting is more complex.
• Intercreditor subordination risk: Where acquisition debt is involved, indemnity recoveries under a share sale may be subordinated to senior lender claims under an intercreditor agreement. Industry observers expect this to become an increasingly contested negotiation point as lenders tighten covenant packages.

Financing, Security and Intercreditor Effects

The private equity deal structure chosen directly affects how lenders take security and how the intercreditor waterfall operates post-completion.

• Share sale, lender perspective: The lender takes a share pledge over the target company’s shares and a debenture over the target’s assets. However, all historic liabilities remain within the target group, meaning the lender’s security pool is exposed to contingent claims. Change-of-control clauses in the target’s existing debt facilities may require refinancing or lender consent, adding cost and delay.
• Asset sale, lender perspective: The lender takes security directly over the acquired assets via a debenture or specific asset charges. Because only identified liabilities transfer, the secured asset base is cleaner. This is generally preferred by acquisition lenders and can result in better financing terms.
• Intercreditor consequences: In share sale structures, indemnity recoveries owed to the buyer may rank behind senior debt in the intercreditor waterfall. Escrow accounts are sometimes structured as “ring-fenced” to sit outside the lender’s security, but this requires explicit intercreditor consent and careful drafting.

Negotiation checklist for PE sponsors: confirm whether the target’s existing facilities contain change-of-control triggers; agree escrow ring-fencing with the lender before signing heads of terms; and model the impact of indemnity subordination on the buyer’s effective recovery rate under warranties.

Employment and Regulatory Considerations

In a share sale, employees remain employed by the same legal entity, no transfer occurs. Contracts of employment, pension rights and continuity of service are unaffected. This is the simplest outcome from an employment law perspective.

In an asset sale, the Transfer of Undertakings (Protection of Employment) Regulations 2006 apply wherever a business or an organised part of a business transfers. Employees assigned to the transferring undertaking automatically become employees of the buyer on their existing terms. The buyer inherits all rights, obligations and liabilities connected with those contracts of employment. Both parties must comply with TUPE information and consultation requirements; failure to do so exposes the buyer (and potentially the seller) to claims of up to 13 weeks’ pay per affected employee.

Licences, regulatory approvals and permits present a parallel concern. In a share sale, these generally continue because the licensed entity has not changed. In an asset sale, licences are frequently non-assignable and must be re-applied for, a process that can delay or even block completion in regulated sectors such as financial services, healthcare or defence.

Enforceability and Dispute Resolution

The practical enforceability of post-completion remedies differs materially between structures.

• Share sale warranties: Claims are brought against the individual sellers under the SPA. Where the seller is a PE fund vehicle that distributes proceeds and winds down, enforceability depends on escrow provisions, guarantee structures or W&I insurance. Limitation periods for contractual warranty claims are typically governed by the SPA’s own survival provisions (shorter than the statutory 6-year limitation for contract claims under the Limitation Act 1980).
• Asset sale warranties: Claims are brought against the selling corporate entity, which, if it remains solvent and operational, is usually easier to locate and pursue than dispersed individual shareholders. However, if the seller enters liquidation, warranty claims rank as unsecured creditor claims.
• W&I insurance as a bridge: In PE transactions, W&I insurance is the primary mechanism for bridging enforcement gaps. The policy survives regardless of the seller’s solvency or availability, giving the buyer direct recourse to an insurer for covered warranty and indemnity breaches.

Jurisdiction and choice-of-law clauses should be agreed early. England and Wales law and exclusive English court jurisdiction (or LCIA arbitration for cross-border deals) remain the standard defaults in UK PE transactions.

What Changes in 2026

Two market-level shifts are reshaping the share sale vs asset sale UK landscape in 2026. First, elevated base rates have increased acquisition-debt costs. Buyers financing through senior secured facilities face tighter covenants and less lender appetite for indemnity or escrow structures that compete with the lender’s own security package. The likely practical effect is that buyers in leveraged deals increasingly either push for asset sales, where the lender’s security is cleaner, or insist on larger W&I policies and ring-fenced escrows if proceeding via share sale.

Second, intercreditor agreements have become more prescriptive. Early indications suggest that lenders are less willing to permit indemnity recoveries to rank pari passu with senior debt, and are requiring longer standstill periods before warranty claims can be enforced. For PE sellers, this means the W&I insurance policy, rather than seller indemnities, has become the primary buyer comfort mechanism, and its cost is now a standard line item in deal economics.

For sellers, the strategic response is to present a robust vendor due diligence package, offer a stapled W&I policy, and price in the cost of the policy to keep escrows minimal and the share sale structure intact. For buyers, the response is to ensure the W&I policy scope, retention level and exclusions are negotiated as rigorously as the SPA itself.

Decision Framework: When to Choose a Share Sale vs an Asset Sale

Choose a share sale when:

• Sellers are individuals who qualify for BADR and want a CGT-efficient clean exit
• The target has a manageable liability profile confirmed through vendor due diligence
• A W&I policy can be stapled or placed at acceptable cost to bridge buyer warranty risk
• Contracts and licences contain change-of-control restrictions rather than assignment restrictions (making share sale simpler than novation)
• PE fund life constraints require a fast, certain close

Choose an asset sale when:

• The target has material contingent or environmental liabilities the buyer does not want to assume
• The buyer needs a tax step-up on goodwill, IP or other intangible assets to improve post-acquisition cash flow
• Acquisition lenders require clean asset-level security without exposure to historic liabilities
• The buyer only wants part of the target’s business, a specific division, product line or territory
• TUPE transfer complexity and contract novation timelines are commercially acceptable

Heads of terms checklist

Regardless of the structure chosen, the following items should be addressed in heads of terms:

• Purchase price mechanics: completion accounts, locked box, or hybrid, specify which and allocate interest/leakage risk
• Tax indemnity carve-outs: scope, cap and survival period; whether the tax indemnity sits inside or outside the general indemnity cap
• Escrow size and release: percentage of consideration, release milestones (typically 12–24 months), and whether ring-fenced from lender security
• W&I insurance allocation: which party procures, who pays premium, retention level and policy exclusions
• Intercreditor notice: confirm lender consent requirements, change-of-control triggers, and indemnity subordination terms
• Novation/consent plan (asset sales): identify material contracts requiring counterparty consent and set a consent timeline with default provisions

When and Why to Engage a Lawyer

The share sale vs asset sale decision is not one to finalise without specialist M&A counsel. The following trigger points should prompt immediate engagement:

• Pre-LOI structuring: before signing a letter of intent or heads of terms, the structure must be agreed here because it determines price allocation, tax treatment and due diligence scope
• Tax optimisation: when BADR eligibility, TOGC conditions, or double-taxation risk requires HMRC-aligned structuring advice
• Warranty and indemnity negotiation: when the SPA warranty schedule, indemnity caps, baskets and survival periods are being drafted, these clauses allocate millions of pounds of post-completion risk
• Intercreditor or lender consent: when acquisition debt is involved and the lender’s intercreditor agreement affects indemnity recovery, escrow ring-fencing or change-of-control triggers
• TUPE and regulatory transfers: when the asset sale involves a regulated business, non-assignable licences, or a workforce where TUPE consultation obligations apply

Key questions to put to your M&A lawyer at the outset: Does the seller qualify for BADR? Will the structure trigger change-of-control clauses in the target’s existing contracts or debt facilities? Can the W&I market cover the identified risk profile? What intercreditor consents are required from the buyer’s lenders? Find M&A lawyers in the United Kingdom through the Global Law Experts directory to begin that conversation.

Sources

1. HM Revenue & Customs, Business Asset Disposal Relief (BADR)
2. HMRC, Capital Gains Tax
3. HMRC, Corporation Tax Rates
4. GOV.UK, Stamp Duty on Shares
5. UK Government, TUPE Regulations 2006
6. Companies Act 2006
7. Practical Law, Acquisition Structures (Asset vs Share)
8. Brodies LLP, Asset Sale v Share Sale
9. Greenwoods Legal, Share Sale v Asset Sale
10. LexisNexis UK, Tax Guidance on Share vs Asset Sale